The Pink Vaccine

The Pink Vaccine

During the summer of 2010, Dr. Vincent Tuohy of the Cleveland Clinic and his team of researchers published their findings about the first preventive breast cancer vaccine in the prestigious journal Nature Medicine. The Pink Vaccine was found to be 100 percent effective in preventing breast cancer in mice that were bred to develop the disease. In the control group, all of the mice developed breast cancer while those who received the vaccination did not.

Tuohy’s team used the protein alpha-lactalbumin as the primary target for his vaccine and found that it both prevented breast cancer and stopped the growth of already existing tumors in animal models. Alpha-lactalbumin is found in the majority of women who are diagnosed with breast cancer, but not in healthy women other than those who are nursing. The plan would be to vaccinate women who are past child-bearing age.

We believe that this vaccine will someday be used to prevent breast cancer in adult women in the same way that vaccines prevent polio and measles in children. If it works in humans the way it works in mice, this will be monumental. We could eliminate breast cancer.

Dr. Vincent Tuohy

Immunologist, Cleveland Clinic’s Lerner Research Institute

The Next Steps

The next step to with this research is to start clinical trials and determine whether the Pink Vaccine is as safe and effective in women as it is in mice. The only problem that’s been standing in the way of Dr. Vincent Tuohy’s research is the lack of funding. Major breast cancer organizations have turned down his request for funds. The Susan G. Komen Foundation, for instance, has turned down Tuohy’s request three separate times! Avon as well as the Department of Defense also refuse to fund further research on Tuohy’s vaccine. However, despite these setbacks, a strong and growing grassroots effort by women around the globe has been developing to fund the preventive breast cancer vaccine. The Breast Health and Healing Foundation supports the research behind the Pink Vaccine. All of the donations that our Foundation receives will be going directly to funding the research behind the preventive breast cancer vaccine and the human mammary tumor virus.

Recent Vaccine News

Rate of Breast Cancer Deaths Predicted to Double by 2030

Women around the globe need to be aware of their cancer risks. The latest research published The Lancet medical journal finds that cancer deaths are predicted to rise 60 percent by the year 2030, according to PBS WGBH. These cancer deaths stem from both breast and...

read more

Biotech Companies Target Personalized Cancer Vaccines

Cancer research has come a long way from the typical medication-based, surgical, chemotherapy, or radiation type of treatments. Today immunotherapies are making a significant headway in battling breast cancer among other types of oncological diseases. Cancer vaccines...

read more

36 Newark Ave., Suite 130
Belleville, NJ  07109

(973) 450-2710

Scientific Breakthroughs Start Here!

We believe there's a better way-- and we are going to find it! Join our mailing list to receive the latest news and updates from our team.

You have Successfully Subscribed!